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DISCUSSION
State of Art
Chios mastic gum is a resin generated by the plant Pistacia lentiscus var.
chia, generally cultivated in Mediterranean countries and particularly in the
southern part of the Greek island of Chios. P. lentiscus is a very ancient
plant and the related gum has been used since many centuries. Recent
studies have associated specific pharmaceutical properties of Chios
mastic gum with its particular molecular components. In fact, increasing
scientific evidences are available on the therapeutic activity of Chios
mastic gum. Its gastro-intestinal, antioxidant, anti-inflammatory,
antidiabetic, antimicrobial and anticancer activity, as well as its beneficial
effects in oral hygiene and in skin care are largely documented. In
particular, it is used as a seasoning in Mediterranean cuisine, in the
production of chewing gum, in perfumery, in dentistry, and for the relief of
epigastric pain and protection against peptic ulcer.
State of Art
Analytical Evaluation
In conclusion, due to its large heterogeneity, (Chios) mastic gum and its
molecular components are not well characterized in relationship with the
substantiation of biological activities and health benefits. However, based on its
fine structural characterization and composition, further studies may generate
novel mastic gum products possessing specific biological activities for new and
specific applications able to produce a beneficial effect in one or more
physiological functions, to increase well-being and/or decrease the risk of
suffering from a particular medical condition.
Up to more than 70 constituents of Chios mastic gum have been found
and more than 60 have been identified. Six components, namely α-
pipene, β-pipene, β-myrcene, linalool, trans-caryophyllene and
camphene, account for 65% to 80% of the weight of the Chios mastic
gum. The active components contributing to its therapeutic effects belong
to the class of terpenes (mono- and sesquiterpenoids, triterpenic acids
and triterpenoids). Triterpenic acids, in particular, possess various
biological capacities such as anti-inflammatory, antioxidant,
antiatherogenic, antihyperlipidemic, anti-tumor, antidiabetic and
hepatoprotective effects. Chios mastic gum has been demonstrated to
contain many of these active molecules such as oleanonic acid, moronic
acid, 24Z-masticadienonic acid, 24Z-isomasticadienonic acid, 24Z-
masticadienolic acid, 24Z-isomasticadienolic acid.
In an adjuvant arthritis (AAR) animal m Green alcool 60% odel of polyarthritis 
(osteoarthritis and rheumatoid arthritis) widely used for preclinical tests, non-animal CS 
of fermentation origin was capable of significantly reducing the severity of arthritis along 
with oxidative stress, a consequence of chronic inflammatory processes occurring in 
AAR. The higher dose of all administered CS (900 mg/kg) was significantly effective in 
decreasing the arthritic score. 
Results and Discussion
Analytical Evaluation
(m/z)-1 SPECIES Peak Number
453 C30H46O3
Oleanonic acid
Moronic acid
24Z-isomasticadienonic acid
24Z-masticadienonic acid
42, 44, 52, 53
455 C30H48O3
Oleanolic acid
24Z-masticadienolic acid
24Z-isomasticadienolic acid
41, 47
469 C30H46O4
Enoxolone acid
Albasapogenin acid
Coleonolic acid
Glycyrrhetinic acid
20, 25, 26, 30,
31, 32, 34, 35,
37, 38, 41, 43
471 C30H46O3
Hederagenic acid
Maslinic acid
Corosolic acid
50
501 C30H46O6
If analyzed by tandem m ss, the
fragmentation pattern belongs to structural
isomers of terpenic acids
7, 8, 15, 27
Analytical Evaluation
To date, there is a substantial lacking of information concerning the fine structural
molecular composition and characterization of Chios mastic gum and its derivatives to
have a established structure/composition and effect/activity relationship to ensure
consumers about its consumption. The present study deals with new recent analytical
approaches useful for the determination of Chios mastic gum terpenes and evaluation of
its quality. In fact, a qualitative and quantitative characterization of mastic gum
biomolecules is of interest to "design" extracts having specific and powerful biological
activities. Moreover, recent analytical techniques can be applied for the determination of
typical fingerprints of mastic gum and a reliable identification of a large number of
terpene components in extracts used in medicine and nutraceuticals. In our laboratory
we developed and validated an analytical procedure for quantification of bioactive
substances in Chios mastic gum, in particular HPLC-(UV)-ESI-MS (and tandem mass)
for an accurate assessment of the content of these compounds. The present results
prove that HPLC-(UV)-ESI-MS is an attractive tool for the identification of the main
constituents of mastic gum and for qualitative and quantitative analysis of marker
compounds as well as it may provide alternatives to classical analytical phytochemistry
to screen commercial preparations of mastic gum and to evaluate specific nutraceutical
benefits.
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